MicroRNA 3934 (miR-3934)

MicroRNA 3934 (miR-3934) is a small, endogenous, non-coding RNA molecule classified as a microRNA, functioning primarily in the post-transcriptional regulation of gene expression by binding to complementary sequences on target mRNAs, resulting in translational repression or mRNA degradation[5]. In cancer biology, miR-3934-5p has been shown to be upregulated in several tumor types, including non-small cell lung carcinoma and neuroblastoma, where it contributes to promoting tumor cell proliferation and inhibiting apoptosis by directly targeting genes such as TP53INP1[2][3][5]. Experimental modulation of miR-3934-5p levels using mimics or inhibitors alters cell sensitivity to chemotherapeutic agents (e.g., cisplatin), indicating its potential as both a therapeutic target and a biomarker for drug response[2]. Further research is needed to fully clarify its disease associations and therapeutic applications.

Other names

MIR3934hsa-mir-3934microRNA-3934miR-3934-5p

Gene silencing via post-transcriptional repression: miR-3934 binds to the 3′ untranslated region (3′UTR) of target mRNAs (e.g., TP53INP1), reducing their expression and affecting downstream processes including apoptosis and proliferation[2][3].